A Pilot Study of Diffusion-Weighted MRI in Patients Undergoing Neoadjuvant Chemoradiation for Pancreatic Cancer

A Pilot Study of Diffusion-Weighted MRI in Patients Undergoing Neoadjuvant Chemoradiation for Pancreatic Cancer

PURPOSE: In the current study we examined the ability of diffusion MRI (dMRI) to predict pathologic response in pancreatic cancer patients receiving neoadjuvant chemoradiation. METHODS: We performed a prospective pilot study of dMRI in patients with resectable pancreatic cancer. Patients underwent d...

Full description

Bibliographic Details
Main Authors:	Kyle C. Cuneo, Thomas L. Chenevert, Edgar Ben-Josef, Mary U. Feng, Joel K. Greenson, Hero K. Hussain, Diane M. Simeone, Matthew J. Schipper, Michelle A. Anderson, Mark M. Zalupski, Mahmoud Al-Hawary, Craig J. Galban, Alnawaz Rehemtulla, Felix Y. Feng, Theodore S. Lawrence, Brian D. Ross
Format:	Article
Language:	English
Published:	Elsevier 2014-10-01
Series:	Translational Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523314000783

Similar Items

Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy
by: Dipankar Ray, et al.
Published: (2015-09-01)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
by: Habermehl Daniel, et al.
Published: (2012-03-01)

Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities
by: Samuel Aguiar Junior, et al.
Published: (2009-11-01)

Opportunities and limitations of CT - assessment of neoadjuvant chemoradiation therapy of gastric cancer
by: T. A. Agababyan, et al.
Published: (2019-12-01)

The influence of neoadjuvant chemoradiation for lower rectal cancer on urinary function
by: Yugo Hirata, et al.
Published: (2019-07-01)

Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer
by: David Wittmann, et al.
Published: (2020-04-01)

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities
by: Dueck Amylou C, et al.
Published: (2011-08-01)

Total laparoscopic and thoracoscopic Ivor Lewis esophagectomy after neoadjuvant Chemoradiation with minimal overall and anastomotic complications
by: Robert E. Merritt, et al.
Published: (2019-06-01)

Neoadjuvant Chemoradiation Compared With Neoadjuvant Radiation Alone in the Management of High-Grade Soft Tissue Extremity Sarcomas
by: Sarah Z. Hazell, MD, et al.
Published: (2020-03-01)

Neoadjuvant Chemotherapy and Adjuvant Chemoradiation Therapy in the Treatment of Resected Gastric Adenocarcinoma: A Case Series
by: Christina Hadzitheodorou, et al.
Published: (2017-04-01)

Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
by: Iacopino Bruno, et al.
Published: (2009-04-01)

Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus
by: Stefan Münch, et al.
Published: (2019-04-01)

Neoadjuvant chemoradiation with capcitabine and celecoxib in stage II and III rectal adenocarcinoma
by: Aghili M, et al.
Published: (2010-10-01)

Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
by: Delphine Dayde, et al.
Published: (2017-03-01)

Neoadjuvant Concurrent Chemoradiation for Curative Treatment of Penile Squamous Cell Carcinoma
by: Arpit Chhabra, et al.
Published: (2014-01-01)

Timing of Esophagectomy after Neoadjuvant Chemoradiation Therapy Affects the Incidence of Anastomotic Leaks
by: Simon Roh, et al.
Published: (2019-02-01)

Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
by: Shaoyu Zhu, et al.
Published: (2019-11-01)

Neoadjuvant Chemoradiation Combined with Regional Hyperthermia in Locally Advanced or Recurrent Rectal Cancer
by: Oliver J. Ott, et al.
Published: (2021-03-01)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
by: Tsz Him So, FRCR, et al.
Published: (2020-09-01)

Neoadjuvant chemoradiation therapy for locally advanced colorectal cancer in hypofractionation mode (case report)
by: S. I. Tkachev, et al.
Published: (2019-11-01)

The changes of tumour vascular endothelial growth factor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma
by: David Buka, et al.
Published: (2017-03-01)

Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer
by: Delphine Dayde, et al.
Published: (2021-07-01)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
by: Fabiana Bettoni, et al.
Published: (2019-09-01)

The Cross-over Survival curve of Neoadjuvant Chemoradiation in Locally Advanced Esophageal Cancer
by: Jo-Lin Lo, et al.
Published: (2010)

Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation
by: Tania Triantafyllou, et al.
Published: (2020-07-01)

Dinosaurs and Ancient Civilizations: Reflections on the Treatment of Cancer
by: Alnawaz Rehemtulla
Published: (2010-12-01)

Cancer Subclonal Genetic Architecture as a Key to Personalized Medicine
by: Alnawaz Rehemtulla
Published: (2013-12-01)

The Interconnectedness of Cancer Cell Signaling
by: Alnawaz Rehemtulla
Published: (2011-12-01)

Neoplasia: An Anniversary of Progress
by: Alnawaz Rehemtulla
Published: (2007-12-01)

The War on Cancer Rages On
by: Alnawaz Rehemtulla
Published: (2009-12-01)

Overcoming Intratumor Heterogeneity of Polygenic Cancer Drug Resistance with Improved Biomarker Integration
by: Alnawaz Rehemtulla
Published: (2012-12-01)

Neoplasia: The Second Decade
by: Alnawaz Rehemtulla
Published: (2008-12-01)

Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy.
by: Craig J Galbán, et al.
Published: (2015-01-01)

Magnetic-Resonance-Imaging Texture Analysis Predicts Early Progression in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiation
by: Valerio Nardone, et al.
Published: (2019-01-01)

MRI-PATHOLOGICAL PARALLELS WITH THE COMPLETE TUMOR RESPONSE TO NEOADJUVANT CHEMORADIATION TREATMENT OF RECTAL CANCER
by: T. P. Berezoskaya, et al.
Published: (2019-06-01)

Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
by: Katherine V. Trinh, et al.
Published: (2020-09-01)

Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study
by: Guangyuan Liu, et al.
Published: (2019-05-01)

How accurate is MRI to predict response to neoadjuvant chemoradiation in locally advanced rectal cancer?
by: Afsaneh Alikhasi, et al.
Published: (2016-01-01)

PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study
by: Entesar Dalah, et al.
Published: (2018-10-01)

Predictors of tumor response to neoadjuvant chemoradiation in locally advanced rectal cancer Egyptian patients
by: Mohamed M. Elmessiry, et al.
Published: (2015-02-01)

Cannot write session to /tmp/vufind_sessions/sess_n3d3b6leknlp5aquhke0ubh3or